Better Buy: Tilray Inc. (NASDAQ:TLRY) vs. Aurora Cannabis Inc. (TSX:ACB)

Tilray Inc. (NASDAQ:TLRY) and Aurora Cannabis Inc. (TSX:ACB) are two frontrunners in the medical cannabis scene. Which pot stock has more upside?

Tilray (NASDAQ: TLRY) is the hottest pot stock out there right now, with its shares nearly quadrupling in just under one month’s time. For many Canadian cannabis investors, the company seemingly came from out of nowhere. With a market cap that’s now nearing $8 billion, established pot firms like Aurora Cannabis (TSX: ACB) will be looking over their shoulder as we head toward legalization day that may see another major leg up for the broader industry.

If you’re perplexed by the sudden entrance of Tilray into the Canadian cannabis scene, you could be forgiven, as the company’s management team decided to take a page out of Canadian stretchy pant maker Lululemon‘s handbook by giving the S&P/TSX Composite Index the cold shoulder. Instead, opt for the more popular NASDAQ exchange with substantially more trading volumes to be had.

Tilray’s decision to become the first marijuana company with an exclusive IPO in the U.S. turned out to be a huge win from a capital-raising perspective as the move that drew a ridiculous amount of attention not only in the U.S., but also at the international level. The NASDAQ exchange is often regarded as one of the most popular exchanges on the planet and the TSX.

Actually, not so much. It doesn’t matter if you’re from Canada, Mexico or Australia, the odds are you’ve got some NASDAQ names in your portfolio, as it contains some of the world’s fastest up-and-coming growth names. So, the NASDAQ IPO listing definitely captured the attention of more investors and speculators.

While Tilray may seem like a game-changing player in the marijuana space, I don’t see any reason why the stock deserves to trade at a premium over incumbents like Aurora Cannabis or any other names in the space.

Is Tilray just another pot stock or is there something extraordinary about the underlying business?

Tilray is a B.C.-based marijuana producer which, like Aurora, focuses on the medical side of the cannabis business. Tilray’s forté is on medical research related to cannabis in addition to cultivation and distribution at the international level.

While I do believe that a massive investment will come from a pharma player, likely in a medical player like Tilray or Aurora, I think Aurora may be the far better value play in the grander scheme of things. The stock was punished for shareholder dilutive acquisitions it’s made in the past.

When you consider the likelihood that an investment made for Aurora (likely from a pharmaceutical behemoth) would carry a massive premium multiple, I think investors ought to forgive the company and pick up its stock, as it has far more upside than Tilray, which trades at a colossal 265.8 times TTM sales versus Aurora’s 185.6 times TTM sales.

I suspect the hype drawn by Tilray’s NASDAQ IPO has caused Tilray stock to trade at an exorbitant premium relative to its true worth. So, with less attention being paid to Aurora, I’d scoop it up while investor focus shifts to other U.S.-traded players.

Foolish takeaway

Aurora is the far better bet today, no question. Unlike other players in the space, Aurora hasn’t enjoyed the same magnitude of positive developments (investment from an established firm or a U.S. listing), which is precisely why I want cannabis investors to own the stock as they take a rain check on Tilray.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Top TSX Stocks

man in business suit pulls a piece out of wobbly wooden tower
Dividend Stocks

Overlooked Canadian Stocks Worth a Closer Look

Explore overlooked Canadian stocks North West Company and West Fraser, with essential retail demand and potential housing recovery upside.

Read more »

Oil industry worker works in oilfield
Energy Stocks

Canadian Natural Resources Has Raised Its Dividend for 26 Straight Years: Here’s Why It Stands Out

Canadian Natural Resources has raised its dividend for 26 straight years. Explore the assets and cash flow supporting its growing…

Read more »

Start line on the highway
Dividend Stocks

2 Simple Canadian Stocks to Buy With $1,000

Looking for Canadian stocks to buy with $1,000? Explore Enbridge and Scotiabank for dividend income and a straightforward long-term starting…

Read more »

up arrow on wooden blocks
Dividend Stocks

Standout Canadian Blue-Chip Stocks to Own in 2027

Explore Canadian blue-chip stocks for 2027, with Canadian National, Fortis and Manulife offering distinct paths to earnings growth and dividend…

Read more »

hiker with backpack in the mountains
Dividend Stocks

Retirement Income: Top Canadian Stocks That Keep Paying Out

Explore top Canadian stocks that keep paying out, with Enbridge, BMO and Granite REIT offering dividend income and monthly distributions

Read more »

3 colorful arrows racing straight up on a black background.
Energy Stocks

Enbridge’s $38 Billion Backlog Is Why This Dividend Stock Remains a Strong Hold

Enbridge’s $38 billion backlog supports its growth outlook. See why this dividend stock remains a strong hold for investors seeking…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Dividend Stocks

Retiring in Canada: Create $750/Month in Dividend Income to Supplement CPP

Retiring soon? See how Scotiabank, Enbridge and XEI can generate $750 a month in dividend income to supplement your CPP…

Read more »